Sponsor Pipeline

Shanghai CureGene Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07619885 The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix®… Acute Coronary Syndromes (ACS) Recruiting
Disease Areas
Stroke (1) Coronary Artery Disease (1)
Get alerts when Shanghai CureGene Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free